Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f8beafe15c0777c1ba9adfb27f5f954 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate |
2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e15e96f56bfb382055dfc636e9d8090 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_745ca3e6d1f4a2051cf0d3beaf831668 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1812106e8884f8810fd59e8ee150d276 |
publicationDate |
2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10344023-B2 |
titleOfInvention |
Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis |
abstract |
The present disclosure is based, in part, on the discovery that disclosed compounds can increase cystic fibrosis transmembrane conductance regulator (CFTR) activity as measured in human bronchial epithelial (hBE) cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11098035-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11083709-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11136313-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10899751-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11248010-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10662207-B2 |
priorityDate |
2014-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |